Abstract:Hypoxia is a common phenomenon among most solid tumors that significantly influences tumor response toward chemo- and radiotherapy. Understanding the distribution and extent of tumor hypoxia in patients will be very important to provide personalized therapies in the clinic. Without sufficient vessels, however, traditional contrast agents for clinical imaging techniques will have difficulty in accumulating in the hypoxic region of solid tumors, thus challenging the detection of hypoxia in vivo. To overcome this problem, herein we develop a novel hypoxia imaging probe, consisting of a hypoxia-triggered self-assembling ultrasmall iron oxide (UIO) nanoparticle and assembly-responding fluorescence dyes (NBD), to provide dual-mode imaging in vivo. In this strategy, we have employed nitroimidazole derivatives as the hypoxia-sensitive moiety to construct intermolecular cross-linking of UIO nanoparticles under hypoxia, which irreversibly form larger nanoparticle assemblies. The hypoxia-triggered performance of UIO self-assembly not only amplifies its T2-weighted MRI signal but also promotes the fluorescence intensity of NBD through its emerging hydrophobic environment incorporated into self-assemblies. In vivo results further confirm that our hypoxic imaging probe can display a prompt MRI signal for the tumor interior region, and its signal enhancement performs a long-term effective feature and gradually reaches 3.69 times amplification. Simultaneously, this probe also exhibits obvious green fluorescence in the hypoxic region of tumor sections. Accordingly, we also have developed a MRI difference value method to visualize the 3D distribution and describe the extent of the hypoxic tumor region within the whole bodies of mice. Due to its notable efficiency of penetration and accumulation inside a hypoxic tumor, our hypoxia imaging probe could also be considered as a potential candidate as a versatile platform for hypoxia-targeted drug delivery, and meanwhile its hypoxia-related therapeutic efficacy can be monitored.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/jacs.0c10245?goto=supporting-info">https://pubs.acs.org/doi/10.1021/jacs.0c10245</a>.Details of the synthesis, TEM images, in vivo and in vitro biocompatibility (<a class="ext-link" href="/doi/suppl/10.1021/jacs.0c10245/suppl_file/ja0c10245_si_001.pdf">PDF</a>)Three-dimensional (3D) distribution of hypoxic areas within the whole body of 4T1 in situ tumor-bearing mice calculated by the MRI difference value method, where the color moves from blue to red to indicate the hypoxic degree enhancement (<a class="ext-link" href="/doi/suppl/10.1021/jacs.0c10245/suppl_file/ja0c10245_si_002.mp4">MP4</a>)This article has not yet been cited by other publications.

An Activatable Near-Infrared Chromophore for Multispectral Optoacoustic Imaging of Tumor Hypoxia and for Tumor Inhibition

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Direct Readout Hypoxia Tumor Suppression in Vivo Through NIR-Theranostic Activation.

Hypoxia-responsive Near Infrared Thioxanthene-Hemicyanine Nanoparticle for Multimodal Imaging-Guided Photothermal/photodynamic Therapy

Hypoxia-triggered single molecule probe for high-contrast NIR II/PA tumor imaging and robust photothermal therapy

A near-infrared multifunctional fluorescent probe for hypoxia monitoring and tumor-targeted therapy

Imaging tumor hypoxia by near-infrared fluorescence tomography.

Hypoxia-activated probe for NIR fluorescence and photoacoustic dual-mode tumor imaging

Azo-based Small Molecular Hypoxia Responsive Theranostic for Tumor-Specific Imaging and Therapy

Tumor-Specific NIR-Activatable Nanoreactor for Self-Enhanced Multimodal Imaging and Cancer Phototherapy.

Azo-based near-infrared fluorescent theranostic probe for tracking hypoxia-activated cancer chemotherapy in vivo.

Smart On-Site Immobilizable Near-Infrared II Fluorescent Nanoprobes for Ultra-Long-Term Imaging-Guided Tumor Surgery and Photothermal Therapy

Peroxynitrite-Responsive Near-Infrared Fluorescent Imaging Guided Synergistic Chemo-Photodynamic Therapy Via Biomimetic Metal-Organic Frameworks.

In Situ Nanozyme-Amplified NIR-II Phototheranostics for Tumor-Specific Imaging and Therapy

An Unsymmetrical Squaraine-based Activatable Probe for Imaging Lymphatic Metastasis through Responding to Tumor Hypoxia by MSOT and Aggregation-enhanced Fluorescent Imaging.

Peroxynitrite Activatable NIR-II Probe for Tumor Diagnosis and Photothermal Therapy in Vivo

A General Approach to Design Dual Ratiometric Fluorescent and Photoacoustic Probes for Quantitatively Visualizing Tumor Hypoxia Levels in Vivo

A Ph-Activatable And Aniline-Substituted Photosensitizer For Near-Infrared Cancer Theranostics

Hypoxia-Triggered Self-Assembly of Ultrasmall Iron Oxide Nanoparticles to Amplify the Imaging Signal of a Tumor

Activatable Near Infrared Dye Conjugated Hyaluronic Acid Based Nanoparticles As a Targeted Theranostic Agent for Enhanced Fluorescence/ct/photoacoustic Imaging Guided Photothermal Therapy

Tumor Microenvironment-Activatable Phototheranostic: Leveraging Nitric Oxide and Weak Acidity As Dual Biomarkers for Ratiometric Fluorescence, Photoacoustic Imaging, and Photothermal Therapy